Onconetix Historical Financial Ratios

ONCO Stock  USD 0.47  0.14  22.95%   
Onconetix is promptly reporting on over 79 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 748 will help investors to properly organize and evaluate Onconetix financial condition quickly.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Onconetix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.

About Onconetix Financial Ratios Analysis

OnconetixFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Onconetix investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Onconetix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Onconetix history.

Onconetix Financial Ratios Chart

At this time, Onconetix's Capex Per Share is very stable compared to the past year.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Onconetix stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Onconetix sales, a figure that is much harder to manipulate than other Onconetix multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.
Most ratios from Onconetix's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Onconetix current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Onconetix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.At this time, Onconetix's Capex Per Share is very stable compared to the past year.
 2023 2024 (projected)
Days Sales Outstanding841.3747.82
PTB Ratio2.312.2

Onconetix fundamentals Correlations

0.411.0-0.910.920.78-0.710.560.411.00.790.1-0.720.870.02-0.951.00.28-0.66-0.8-0.14-0.660.290.80.17-0.66
0.410.41-0.590.480.47-0.39-0.091.00.410.47-0.73-0.540.460.84-0.470.41-0.37-0.19-0.420.29-0.20.180.14-0.69-0.19
1.00.41-0.910.920.78-0.710.560.411.00.790.1-0.720.870.02-0.951.00.28-0.66-0.8-0.14-0.660.290.80.17-0.66
-0.91-0.59-0.91-0.98-0.930.88-0.64-0.59-0.91-0.94-0.050.91-0.98-0.10.93-0.90.00.780.90.270.78-0.09-0.86-0.120.78
0.920.480.92-0.980.88-0.810.640.480.920.890.12-0.830.970.02-0.970.920.18-0.76-0.96-0.23-0.760.20.870.19-0.76
0.780.470.78-0.930.88-0.990.820.470.781.00.25-0.990.97-0.07-0.760.78-0.24-0.93-0.78-0.53-0.93-0.250.910.31-0.93
-0.71-0.39-0.710.88-0.81-0.99-0.84-0.39-0.71-0.98-0.340.99-0.930.170.66-0.70.340.930.70.660.930.4-0.92-0.390.93
0.56-0.090.56-0.640.640.82-0.84-0.090.560.820.71-0.750.76-0.57-0.510.55-0.1-0.96-0.56-0.73-0.96-0.430.870.75-0.96
0.411.00.41-0.590.480.47-0.39-0.090.410.47-0.73-0.540.460.84-0.470.41-0.37-0.19-0.420.29-0.20.180.14-0.69-0.19
1.00.411.0-0.910.920.78-0.710.560.410.790.1-0.720.870.02-0.951.00.28-0.66-0.8-0.14-0.660.290.80.17-0.66
0.790.470.79-0.940.891.0-0.980.820.470.790.25-0.990.97-0.07-0.770.78-0.24-0.93-0.78-0.53-0.93-0.250.910.31-0.93
0.1-0.730.1-0.050.120.25-0.340.71-0.730.10.25-0.170.22-0.98-0.020.10.14-0.49-0.1-0.79-0.49-0.470.541.0-0.49
-0.72-0.54-0.720.91-0.83-0.990.99-0.75-0.54-0.72-0.99-0.17-0.930.00.69-0.720.380.890.720.550.890.33-0.86-0.230.89
0.870.460.87-0.980.970.97-0.930.760.460.870.970.22-0.93-0.06-0.890.86-0.03-0.88-0.9-0.42-0.88-0.040.930.29-0.88
0.020.840.02-0.10.02-0.070.17-0.570.840.02-0.07-0.980.0-0.06-0.10.02-0.210.32-0.020.710.320.4-0.4-0.970.32
-0.95-0.47-0.950.93-0.97-0.760.66-0.51-0.47-0.95-0.77-0.020.69-0.89-0.1-0.94-0.360.630.930.020.63-0.42-0.76-0.090.63
1.00.411.0-0.90.920.78-0.70.550.411.00.780.1-0.720.860.02-0.940.28-0.65-0.79-0.14-0.650.290.790.17-0.65
0.28-0.370.280.00.18-0.240.34-0.1-0.370.28-0.240.140.38-0.03-0.21-0.360.280.21-0.280.420.210.810.020.160.21
-0.66-0.19-0.660.78-0.76-0.930.93-0.96-0.19-0.66-0.93-0.490.89-0.880.320.63-0.650.210.670.641.00.38-0.89-0.541.0
-0.8-0.42-0.80.9-0.96-0.780.7-0.56-0.42-0.8-0.78-0.10.72-0.9-0.020.93-0.79-0.280.670.150.67-0.29-0.8-0.170.67
-0.140.29-0.140.27-0.23-0.530.66-0.730.29-0.14-0.53-0.790.55-0.420.710.02-0.140.420.640.150.630.81-0.66-0.780.64
-0.66-0.2-0.660.78-0.76-0.930.93-0.96-0.2-0.66-0.93-0.490.89-0.880.320.63-0.650.211.00.670.630.38-0.89-0.541.0
0.290.180.29-0.090.2-0.250.4-0.430.180.29-0.25-0.470.33-0.040.4-0.420.290.810.38-0.290.810.38-0.2-0.440.38
0.80.140.8-0.860.870.91-0.920.870.140.80.910.54-0.860.93-0.4-0.760.790.02-0.89-0.8-0.66-0.89-0.20.59-0.89
0.17-0.690.17-0.120.190.31-0.390.75-0.690.170.311.0-0.230.29-0.97-0.090.170.16-0.54-0.17-0.78-0.54-0.440.59-0.54
-0.66-0.19-0.660.78-0.76-0.930.93-0.96-0.19-0.66-0.93-0.490.89-0.880.320.63-0.650.211.00.670.641.00.38-0.89-0.54
Click cells to compare fundamentals

Onconetix Account Relationship Matchups

Pair Trading with Onconetix

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Onconetix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onconetix will appreciate offsetting losses from the drop in the long position's value.

Moving together with Onconetix Stock

  0.84VALN Valneva SE ADRPairCorr
  0.76ERNA Eterna TherapeuticsPairCorr

Moving against Onconetix Stock

  0.81BMY Bristol Myers SquibbPairCorr
  0.76GILD Gilead SciencesPairCorr
  0.72ESPR Esperion TherapeuticsPairCorr
  0.66DYAI Dyadic InternationalPairCorr
  0.35DNA Ginkgo Bioworks HoldingsPairCorr
The ability to find closely correlated positions to Onconetix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Onconetix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Onconetix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Onconetix to buy it.
The correlation of Onconetix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Onconetix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Onconetix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Onconetix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Onconetix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Onconetix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Onconetix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Onconetix Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Onconetix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Onconetix. If investors know Onconetix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Onconetix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(83.48)
Revenue Per Share
2.892
Return On Assets
(0.22)
Return On Equity
(17.58)
The market value of Onconetix is measured differently than its book value, which is the value of Onconetix that is recorded on the company's balance sheet. Investors also form their own opinion of Onconetix's value that differs from its market value or its book value, called intrinsic value, which is Onconetix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Onconetix's market value can be influenced by many factors that don't directly affect Onconetix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Onconetix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Onconetix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Onconetix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.